Literature DB >> 6308969

The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme.

J Boëthius, H Blomgren, V P Collins, T Greitz, H Strander.   

Abstract

This report presents the results of a phase I trial of the value of human leucocyte interferon-alpha in the treatment of glioblastoma. Twelve patients entered the trial. In one case we believe that the patient benefitted from the interferon treatment. CT scans of patients on interferon did not reveal the true extent of the tumorous tissue.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6308969     DOI： 10.1007/bf01401182

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  15 in total

1.  Interferon therapy in Hodgkin's disease. A case report.

Authors:  H Blomgren; K Cantell; B Johansson; C Lagergren; U Ringborg; H Strander
Journal:  Acta Med Scand       Date:  1976

2.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

3.  The treatment of glioblastoma multiforme of the brain.

Authors:  R Jelsma; P C Bucy
Journal:  J Neurosurg       Date:  1967-11       Impact factor: 5.115

4.  Partial purification of human leukocyte interferon on a large scale.

Authors:  K Cantell; S Hirvonen; V Koistinen
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy.

Authors:  D L Sweet; F J Hendler; K Hanlon; J Hekmatpanah; M L Griem; E E Duda; B Mulligan; R L Wollman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

6.  In vitro demonstration of an endothelial proliferative factor produced by neural cell lines.

Authors:  R L Suddith; P J Kelly; H T Hutchison; E A Murray; B Haber
Journal:  Science       Date:  1975-11-14       Impact factor: 47.728

7.  CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme.

Authors:  F Cianfriglia; A Pompili; A Riccio; A Grassi
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

8.  Endothelial growth factor present in tissue culture of CNS tumors.

Authors:  P J Kelly; R L Suddith; H T Hutchison; K Werrbach; B Haber
Journal:  J Neurosurg       Date:  1976-03       Impact factor: 5.115

9.  Human leukocyte interferon therapy for advanced ovarian carcinoma.

Authors:  N Einhorn; K Cantell; S Einhorn; H Strander
Journal:  Am J Clin Oncol       Date:  1982-04       Impact factor: 2.339

10.  Migration of capillary endothelial cells is stimulated by tumour-derived factors.

Authors:  B R Zetter
Journal:  Nature       Date:  1980-05-01       Impact factor: 49.962
View more
  15 in total

Review 1.  Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.

Authors:  Steven De Vleeschouwer; Stefaan W Van Gool; Frank Van Calenbergh
Journal:  Childs Nerv Syst       Date:  2004-09-28       Impact factor: 1.475

2.  Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors.

Authors:  A Boiardi; A Silvani; I Milanesi; L Munari; G Broggi; M Botturi
Journal:  Ital J Neurol Sci       Date:  1991-04

Review 3.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

4.  Inhibition of wound healing in mice by local interferon alpha/beta injection.

Authors:  A J Stout; I Gresser; W D Thompson
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

5.  Distribution of mouse interferon-beta in normal and brain tumour-bearing mice.

Authors:  Y Mihara; J Kuratsu; S Takaki; K Hori; E Nagai; Y Satoh; N Minowa; Y Ushio
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 6.  Cytokine networks in glioma.

Authors:  Kenichiro Iwami; Atsushi Natsume; Toshihiko Wakabayashi
Journal:  Neurosurg Rev       Date:  2011-06-09       Impact factor: 3.042

7.  Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme.

Authors:  R Martínez; J Vaquero; J Ramiro; F García Salazar; S De Oya
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

8.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

9.  The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma--a phase II study.

Authors:  K R von Wild; T H Knocke
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

10.  Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme.

Authors:  M D Groves; V K Puduvalli; M R Gilbert; V A Levin; C A Conrad; V H Liu; K Hunter; C Meyers; K R Hess; W K Alfred Yung
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.